Characteristics of accountable care organizations offering methadone to patients with opioid use disorder.

Maia Crawford, Benjamin A Barsky, Haiden A Huskamp, Mary F Brunette, Ellen Meara

Abstract read

In one paragraph

Article in Health affairs scholar, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maia CrawfordThe Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA.ORCID https://orcid.org/0000-0002-6816-5835

Benjamin A BarskyUniversity of California College of the Law, San Francisco, CA 94102, USA.

Haiden A HuskampDepartment of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA.

Mary F BrunetteThe Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA.

Ellen MearaDepartment of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.ORCID https://orcid.org/0000-0003-0211-1970

Funding

Stemming the Tide: The Role of Payment and Delivery System Reform in Combating the Opioid EpidemicR01DA049757 · NIDA · DARTMOUTH COLLEGE · PI LEWINSON, TERRI D, MEARA, ELLEN R. · 2020 to 2023

$2.6M

NIDA NIH HHS R01 DA049757

6 · The paper itself

Abstract

Understanding whether organizations with Medicare and Medicaid accountable care organization (ACO) contracts offer methadone provides important context about how organizations invested in payment and delivery system reform address the needs of patients with substance use disorders. We used data from the 2021-2022 National Survey of Accountable Care Organizations to assess whether organizations with ACO contracts, which are held accountable for the cost and quality of care for an assigned patient population, offered methadone to patients with opioid use disorder (OUD), and the organizational and contextual characteristics associated with doing so. We found that 28.3% of survey respondents reported that clinicians in their organizations offered methadone via an opioid treatment program. In adjusted analyses, organizations with a Medicaid ACO contract but no Medicare contract were more likely to offer methadone (46.0%,

Indexed as

accountable care organizationsmethadoneopioid use disordersubstance use disordersurvey

Identifiers

PMID40271096

DOI10.1093/haschl/qxaf074

PMCPMC12015604

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.